p.67 抽出テキスト

patients supported with an axial-flow left ventricular assist device. J Heart Lung Transplant 2017; 36: 50-58. PMID: 27746085 359. Kapelios CJ, Charitos C, Kaldara E, et al. Late-onset right ventricular dysfunction after mechanical support by a continuous-flow left ventricular assist device. J Heart Lung Transplant 2015; 34: 1604- 1610. PMID: 26163154 360. Kurihara C, Critsinelis AC, Kawabori M, et al. Frequency and Consequences of Right-Sided Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation. Am J Cardiol 2018; 121: 336- 342. PMID: 29223289 361. John R, Kamdar F, Eckman P, et al. Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices. Ann Thorac Surg 2011; 92: 1593-1600. PMID: 22051256 362. Morgan JA, Paone G, Nemeh HW, et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2012; 31: 715-718. PMID: 22425231 363. Kushnir VM, Sharma S, Ewald GA, et al. Evaluation of GI bleeding after implantation of left ventricular assist device. Gastrointest Endosc 2012; 75: 973-979. PMID: 22341716 364. Bartoli CR, Kang J, Restle DJ, et al. Inhibition of ADAMTS-13 by doxycycline reduces von Willebrand factor degradation during supraphysiological shear stress: therapeutic implications for left ventricular assist device-associated bleeding. JACC Heart Fail 2015; 3: 860-869. PMID: 26454844 365. Bartoli CR, Zhang DM, Hennessy-Strahs S, et al. Clinical and in vitro evidence that left ventricular assist device-induced von Willebrand factor degradation alters angiogenesis. Circ Heart Fail 2018; 11: e004638. PMID: 30354363 366. Fraser KH, Zhang T, Taskin ME, et al. A quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index. J Biomech Eng 2012; 134: 081002. PMID: 22938355 367. Molina TL, Krisl JC, Donahue KR, et al. Gastrointestinal bleeding in left ventricular assist device: octreotide and other treatment modalities. ASAIO J 2018; 64: 433-439. PMID: 29406356 368. Namdaran P, Zikos TA, Pan JY, et al. Thalidomide use reduces risk of refractory gastrointestinal bleeding in patients with continuous flow left ventricular assist devices. ASAIO J 2020; 66: 645-651. PMID: 31425265 369. Houston BA, Schneider AL, Vaishnav J, et al. Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices. J Heart Lung Transplant 2017; 36: 380-385. PMID: 28169115 370. Cushing M, Kawaguchi K, Friedman KD, et al. Factor VIII/von Willebrand factor concentrate therapy for ventricular assist deviceassociated acquired von Willebrand disease. Transfusion 2012; 52: 1535-1541. PMID: 22229973 371. Asleh R, Albitar HAH, Schettle SD, et al. Intravenous bevacizumab as a novel treatment for refractory left ventricular assist devicerelated gastrointestinal bleeding. J Heart Lung Transplant 2020; 39: 492-495. PMID: 32173217 372. Vukelic S, Vlismas PP, Patel SR, et al. Digoxin is associated with a decreased incidence of angiodysplasia-related gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices. Circ Heart Fail 2018; 11: e004899. PMID: 30354557 373. Imamura T, Nguyen A, Rodgers D, et al. Omega-3 therapy is associated with reduced gastrointestinal bleeding in patients with continuous-flow left ventricular assist device. Circ Heart Fail 2018; 11: e005082. PMID: 30354397 374. Cowger J, Pagani FD, Haft JW, et al. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail 2010; 3: 668-674. PMID: 20739615 375. Pak SW, Uriel N, Takayama H, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant 2010; 29: 1172-1176. PMID: 20619680 376. Hatano M, Kinugawa K, Shiga T, et al. Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. Circ J 2011; 75: 1147-1155. PMID: 21378448 377. Grinstein J, Kruse E, Sayer G, et al. Accurate quantification methods for aortic insufficiency severity in patients with LVAD: role of diastolic flow acceleration and systolic-to-diastolic peak velocity ratio of outflow cannula. JACC Cardiovasc Imaging 2016; 9: 641-651. PMID: 26684975 378. Grinstein J, Kruse E, Sayer G, et al. Novel echocardiographic parameters of aortic insufficiency in continuous-flow left ventricular assist devices and clinical outcome. J Heart Lung Transplant 2016; 35: 976-985. PMID: 27373822 379. Sayer G, Sarswat N, Kim GH, et al. The Hemodynamic effects of aortic insufficiency in patients supported with continuous-flow left ventricular assist devices. J Card Fail 2017; 23: 545-551. PMID: 28435003 380. Letsou GV, Connelly JH, Delgado RM 3rd, et al. Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? J Heart Lung Transplant 2006; 25: 395-399. PMID: 16563967 381. Imamura T, Kinugawa K, Nitta D, et al. Advantage of pulsatility in left ventricular reverse remodeling and aortic insufficiency prevention during left ventricular assist device treatment. Circ J 2015; 79: 1994-1999. PMID: 26118343 382. Imamura T, Kinugawa K, Nitta D, et al. Opening of aortic valve during exercise is key to preventing development of aortic insufficiency during ventricular assist device treatment. ASAIO J 2015; 61: 514-519. PMID: 25955152 383. Jorde UP, Uriel N, Nahumi N, et al. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients. Circ Heart Fail 2014; 7: 310-319. PMID: 24415682 384. McKellar SH, Deo S, Daly RC, et al. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices. J Thorac Cardiovasc Surg 2014; 147: 344-348. PMID: 23246052 385. Fujita T, Kobayashi J, Hata H, et al. Aortic valve closure for rapidly deteriorated aortic insufficiency after continuous flow left ventricular assist device implantation. J Artif Organs 2013; 16: 98-100. PMID: 22986540 386. Parikh KS, Mehrotra AK, Russo MJ, et al. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics. JACC Cardiovasc Interv 2013; 6: 84-89. PMID: 23347865 387. Yehya A, Rajagopal V, Meduri C, et al. Short-term results with trans catheter aortic valve replacement for treatment of left ventricular

assist device patients with symptomatic aortic insufficiency. J Heart Lung Transplant 2019; 38: 920-926. PMID: 30898555 388. Martins RP, Leclercq C, Bourenane H, et al. Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: New insights from the ASSIST-ICD study. Heart Rhythm 2019; 16: 1506-1512. PMID: 31255846 389. Galand V, Flécher E, Auffret V, et al. ASSIST-ICD Investigators. Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices. JACC Clin Electrophysiol 2018; 4: 1166-1175. PMID: 30236390 390. Makki N, Mesubi O, Steyers C, et al. Meta-analysis of the relation of ventricular arrhythmias to all-cause mortality after implantation of a left ventricular assist device. Am J Cardiol 2015; 116: 1385- 1390. PMID: 26361826 391. Kashiwa K, Nishimura T, Kubo H, et al. Study of device malfunctions in patients with implantable ventricular assist devices living at home. J Artif Organs 2010; 13: 134-138. PMID: 20740372 392. Moazami N, Milano CA, John R, et al. HeartMate II Investigators. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. Ann Thorac Surg 2013; 95: 500-505. PMID: 23261114 393. Birks EJ, Tansley PD, Yacoub MH, et al. Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant 2004; 23: 964-969. PMID: 15312826 394. Jafar M, Gregoric ID, Radovancevic R, et al. Urgent exchange of a HeartMate II left ventricular assist device after percutaneous lead fracture. ASAIO J 2009; 55: 523-524. PMID: 19730010 395. Gregoric ID, Bruckner BA, Jacob L, et al. Clinical experience with sternotomy versus subcostal approach for exchange of the Heart- Mate XVE to the HeartMate II ventricular assist device. Ann Thorac Surg 2008; 85: 1646-1649. PMID: 18442556 396. Adamson RM, Dembitsky WP, Baradarian S, et al. HeartMate left ventricular assist system exchange: results and technical considerations. ASAIO J 2009; 55: 598-601. PMID: 19779301 397. Stulak JM, Cowger J, Haft JW, et al. Device exchange after primary left ventricular assist device implantation: indications and outcomes. Ann Thorac Surg 2013; 95: 1262-1268. PMID: 23063192 398. Lanier GM, Orlanes K, Hayashi Y, et al. Validity and reliability of a novel slow cuff-deflation system for noninvasive blood pressure monitoring in patients with continuous-flow left ventricular assist device. Circ Heart Fail 2013; 6: 1005-1012. PMID: 23811966 399. Saeed O, Jermyn R, Kargoli F, et al. Blood pressure and adverse events during continuous flow left ventricular assist device support. Circ Heart Fail 2015; 8: 551-556. PMID: 25870369 400. Pinsino A, Castagna F, Zuver AM, et al. Prognostic implications of serial outpatient blood pressure measurements in patients with an